J. Bentley et al., THE HUMAN KB MULTIDRUG-RESISTANT CELL-LINE KB-C1 IS HYPERSENSITIVE TOINHIBITORS OF GLYCOSYLATION, Cancer letters, 115(2), 1997, pp. 221-227
We have previously shown that the hypersensitivity of KB MDR cells to
2-deoxy-D-glucose is associated with diminished plasma membrane GLUT-1
levels compared with parental, non-MDR cells. Here we report that MDR
cells are hypersensitive to the N-linked glycosylation inhibitor tuni
camycin, which induces partial inhibition of GLUT-1 glycosylation and
diminishes GLUT-1-mediated transport. The effect of tunicamycin, which
also enhances the hypersensitivity of MDR cells to 2-deoxy-D-glucose,
could not be attributed to alterations in P-glycoprotein activity. Th
e use of agents that act synergistically to diminish the level and act
ivity of GLUT-1 in MDR cells may be of clinical potential. (C) 1997 El
sevier Science Ireland Ltd.